Drug reference
mitiglinide
For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.
Drug class
Endocrine (Insulin secretagogues)
Mechanism of action
Sulfonylureas and meglitinides directly stimulate release of insulin from pancreatic beta cells and thereby lower blood glucose concentrations. Because they work by stimulating insulin secretion, they are useful only in patients with some beta cell function. Adverse effects may include weight gain and hypoglycemia
Common side effects
- Dizziness
- Increased uric acid
- Weight gain
- Flu-like syndrome
- Arthropathy
Related conditions
Frequently asked questions
What drug class is mitiglinide?
mitiglinide belongs to: Endocrine.
How does mitiglinide work?
Sulfonylureas and meglitinides directly stimulate release of insulin from pancreatic beta cells and thereby lower blood glucose concentrations. Because they work by stimulating insulin secretion, they are useful only in patients with some beta cell function. Adverse effects may include weight gain and hypoglycemia
What are the common side effects of mitiglinide?
Dizziness, Increased uric acid, Weight gain, Flu-like syndrome, Arthropathy
Full monographs, dosing and an interaction checker in the MediHelp app
Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.